Received in the Senate and Read twice and referred to the Committee on Homeland Security and Governmental Affairs.
This bill (Gerald E. Connolly Esophageal Cancer Awareness Act of 2025) directs the Government Accountability Office to produce a report within one year.
Scope: FEHB-only study versus calls to include Medicare/Medicaid
Relative to its intended legislative type, this bill is a straightforward GAO report mandate with a clear problem statement and an adequate implementation path (responsible entity and deadline).
This bill (Gerald E.
Connolly Esophageal Cancer Awareness Act of 2025) directs the Government Accountability Office to produce a report within one year.
The GAO must evaluate (1) esophageal cancer–related health care spending under the Federal Employees Health Benefits Program and (2) how often FEHB-covered individuals identified as high-risk receive screening per established guidelines.
Very narrow, noncontroversial reporting requirement with minimal fiscal effect; historically similar GAO-report bills often become law.
Relative to its intended legislative type, this bill is a straightforward GAO report mandate with a clear problem statement and an adequate implementation path (responsible entity and deadline). It specifies two discrete evaluation topics, which match the focused reporting purpose.
Scope: FEHB-only study versus calls to include Medicare/Medicaid
These are examples from the analysis, not a ranked list of the most-affected groups.
Scope: FEHB-only study versus calls to include Medicare/Medicaid
Likely supportive because the bill prioritizes early detection, prevention, and federal oversight of health spending.
Views the GAO study as a basis to expand screening access and reduce mortality, though eventual policy change is speculative.
Generally favorable as a low-cost oversight measure producing evidence to inform policy.
Wants clear methodology, cost estimates, and cautious interpretation before recommending broader action.
Likely supportive but cautious; bill is narrow and nonregulatory, using GAO oversight of federal spending.
Concerned about data access, privacy, and possible downstream pressure for mandates or increased federal health costs.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Very narrow, noncontroversial reporting requirement with minimal fiscal effect; historically similar GAO-report bills often become law.
The bill has not accumulated any surfaced votes yet.
Scope: FEHB-only study versus calls to include Medicare/Medicaid
Very narrow, noncontroversial reporting requirement with minimal fiscal effect; historically similar GAO-report bills often become law.
Relative to its intended legislative type, this bill is a straightforward GAO report mandate with a clear problem statement and an adequate implementation path (responsible entity and deadline). It specifies two discret…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.